EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future

Przemysław Ciszewski, Alicja Drelichowska, Damian Pikor, Emilia Wiśniewska, Michał Azierski

romanian journal of ophthalmology · 2025

DOI: 10.22336/rjo.2025.03 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift romanian journal of ophthalmology, 2025. Verfasst von Przemysław Ciszewski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Association of Ophthalmology, Department of Ophthalmology, Silesian Medical University, Katowice, Poland. Hauptthemen laut MEDLINE: Genetic Therapy, Quality of Life, Geographic Atrophy. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This review explores modern therapeutic options for the dry form of age-related macular degeneration (AMD), a condition representing one of the most significant challenges in ophthalmology due to its progressive nature and lack of effective treatment. The study discusses innovative approaches, evaluates available methods, and examines the potential of emerging technologies to improve patients' quality of life.

Methods

A comprehensive review of current literature was conducted, being focused on therapies for dry AMD, including classical methods such as AREDS/AREDS2 supplementation, molecularly targeted drugs, gene therapy, cell transplants, tissue engineering, nanotechnology, and light-based therapies. Emerging tools leveraging artificial intelligence for personalized treatment and predictive modeling were also evaluated.

Results

AREDS/AREDS2 therapies effectively slow disease progression but cannot reverse retinal damage. Advances include molecularly targeted therapies (Pegcetacoplan, Avacincaptad Pegol) that reduce inflammation, gene therapy (HMR59) protecting RPE cells, and mitochondria-targeted drugs (SS-31) mitigating oxidative stress. Using scaffolds, nanoparticles, tissue engineering, and nanotechnology enhances RPE regeneration and drug delivery. Light-based therapies (LLLT, adaptive phototherapy) improve mitochondrial function, while AI aids in predicting disease progression and personalizing treatment.

Conclusions

Modern therapeutic approaches for dry AMD provide promising avenues to slow disease progression and protect vision. However, further clinical trials are needed to optimize these strategies, assess long-term outcomes, and expand patient access to effective treatments. These advancements have the potential to significantly improve the quality of life for individuals affected by dry AMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyQuality of LifeGeographic AtrophyHumansTissue Engineering

Stichwörter der Autor:innen

AI = Artificial IntelligenceAMDAMD = Age-related Macular DegenerationAREDS = Age-Related Eye Disease StudyAREDS2 = Age-Related Eye Disease Study 2ATP = Adenosine TriphosphateESC(s) = Embryonic Stem Cell(s)FAF = Fundus AutofluorescenceFDA = Food and Drug AdministrationGA = Geographic AtrophyHLA = Human Leukocyte AntigenHRF = Hyperreflective FociLLLT = Low-Level Laser TherapyMAC = Membrane Attack ComplexNGF = Nerve Growth Factor

Autor:innen und Institutionen

  • Scientific Association of Ophthalmology, Department of Ophthalmology, Silesian Medical University, Katowice, Poland.
  • Scientific Association of MedTech at the Center for Remote Learning and Educational Effects Analysis, Faculty of Medical Sciences in Katowice, Silesian Medical University, Katowice, Poland.
  • Department and Clinic of Tropical and Parasitic Diseases, University of Medical Sciences, Poznań, Poland.

Zitieren

APA

Ciszewski, P., Drelichowska, A., Pikor, D., Wiśniewska, E., & Azierski, M. (2025). Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future. romanian journal of ophthalmology. https://doi.org/10.22336/rjo.2025.03

Vancouver

Ciszewski P, Drelichowska A, Pikor D, Wiśniewska E, Azierski M. Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future. romanian journal of ophthalmology. 2025. doi:10.22336/rjo.2025.03

BibTeX
@article{Ciszewski2025,
  author = {Ciszewski, Przemysław and Drelichowska, Alicja and Pikor, Damian and Wiśniewska, Emilia and Azierski, Michał},
  title = {Innovative technologies for the treatment of dry age-related macular degeneration (AMD) - modern therapeutic perspectives and their future},
  journal = {romanian journal of ophthalmology},
  year = {2025},
  doi = {10.22336/rjo.2025.03}
}
Kostenlos starten →